Balan Kottekkattu, Alwis Lankanatha, Sonoda Luke Ienari, Pawaroo Davina, Parry-Jones David R, Middleton Stephen
Department of Nuclear Medicine, Addenbrooke's Hospital, Cambridge, UK.
Nucl Med Commun. 2010 Apr;31(4):328-33. doi: 10.1097/MNM.0b013e328335e5a9.
To review our experience of doing whole gut transit scintigraphy in patients presenting with functional gastrointestinal problems and to determine its clinical usefulness.
All whole gut transit studies using a liquid meal over a 5-year-period were reviewed and clinical outcome assessed.
Fifty-five patients (44 women; mean age 43 years) underwent whole gut transit scintigraphy using indium-111 diethylene triamine penta-acetic acid in water. The main symptoms were constipation (49%), dyspepsia (25%) and diarrhoea (25%). Colonic transit was delayed in 63% of patients with constipation, which was significantly (P=0.005) higher than that in patients with dyspepsia. Delayed colonic transit was also seen in 43% of patients with diarrhoea. Only 26% of patients with constipation had a delay in liquid gastric emptying and small bowel transit. Gastric emptying, small bowel transit and colonic transit were normal in 43, 79 and 29% of patients with dyspepsia, respectively. There was no statically significant difference in gastric emptying and small bowel transit between patients with constipation, diarrhoea and dyspepsia.
Liquid-phase whole gut transit scintigraphy seems to be a useful investigation in patients with chronic gastrointestinal symptoms. Rational use of this modality may help the clinician change the management or better characterize the underlying problem/diagnosis in the majority of patients with functional symptoms.
回顾我们对有功能性胃肠问题患者进行全肠道通过闪烁扫描的经验,并确定其临床实用性。
回顾了5年期间所有使用流质餐的全肠道通过研究,并评估临床结果。
55例患者(44名女性;平均年龄43岁)使用铟-111二乙三胺五乙酸水溶液进行了全肠道通过闪烁扫描。主要症状为便秘(49%)、消化不良(25%)和腹泻(25%)。63%的便秘患者结肠通过延迟,这显著高于消化不良患者(P=0.005)。43%的腹泻患者也出现结肠通过延迟。只有26%的便秘患者存在流质胃排空和小肠通过延迟。消化不良患者中,分别有43%、79%和29%的患者胃排空、小肠通过和结肠通过正常。便秘、腹泻和消化不良患者之间的胃排空和小肠通过无统计学显著差异。
液相全肠道通过闪烁扫描似乎是对慢性胃肠症状患者有用的检查。合理使用这种检查方法可能有助于临床医生改变大多数功能性症状患者的治疗方案或更好地明确潜在问题/诊断。